Profile
Rockeby biomed is a Singapore-based, ASX-listed (ASX: RBY) biotechnology company with offi ces in Australia and Singapore.
The Company specializes in the research, development and marketing of rapid testing technologies for infectious diseases in animals and humans.
The Company’s main market is in-vitro diagnostic testing which includes serology testing in hospitals as well as point of care rapid tests for use by healthcare professionals and consumers inside and outside of traditional healthcare environments.
The additional appointments to the Board and Management team has further strengthened the Company’s leadership and should support the Company with its growth strategies.
Mission
Rockeby aims to be a global research and development biotechnology group specializing
in the diagnosis of infectious diseases in animals and humans. Rockeby is committed to
the discovery, development, marketing and distribution of innovative technologies and new
biotechnology products.
